HomeOnline Training HomeBriefingsNHS Community Pharmacy SCS
Your basket: 0 products    £0.00 View shopping cart
Home
  • NCSCT Shop
    • Midwifery Briefing
    • STP-Pregnancy
    • Vaping Allowed vinyl wall sticker (150x100mm)
    • Vaping Allowed vinyl window sticker - reverse print (150x100mm)
    • Vaping Allowed / No Smoking vinyl window sticker - reverse print (150x100mm)
    • Core competences
    • Very Brief Advice on smoking training DVD
    • 30 Seconds Very Brief Advice on Smoking DVD
    • Very Brief Advice on Secondhand Smoke DVD
    • Good practice for smokefree mental health services
    • Standard Treatment Programme
    • Smoking Cessation and Mental Health: a briefing
    • The Smokefree Formula
    • The Champix Briefing – out of print
  • About us
    • Contact us
    • NCSCT Services 2021
    • Introducing the NCSCT
    • Privacy Policy
    • Frequently asked questions
  • Training resources
    • NCSCT Training Standard
  • Stop smoking medications
    • Cytisine
    • Nicotine Patches
    • Nicotine Inhalator
    • Nicotine Gum
    • Nicotine Nasal Spray
    • Nicotine Mouth Spray
    • Nicotine Microtabs
    • Nicotine Lozenge
    • Varenicline (Champix)
    • Bupropion
    • Voke inhaler
    • Example varenicline PGD and NRT voucher protocol
  • NCSCT briefings
    • Combination NRT
    • Service policy guidance on cannabis use
    • Cannabis briefing
    • Ambulance VBA
    • TEC study findings
    • Stop smoking services: increased chances of quitting
    • Stopping Smoking in Pregnancy: A briefing for maternity care providers
    • 12 week smoking status
    • SCIMITAR +
    • Spontaneous quitters
    • Dental VBA
    • Working with vape shops
    • Mental health briefing
    • Lifestyle service briefing
    • Champix SPC update
    • E-cig briefing V2
    • Prevention v cessation
    • Four week quit rate briefing
    • Smoking Cessation and Mental Health: A briefing for front-line staff
    • Quick wins
    • The 'not-a-puff' rule
    • Smoking and bone health
    • Cost-effectiveness of pharmacotherapy for smoking cessation
    • Smoking reduction
    • Cardiovascular disease and Champix
    • Smoking cessation interventions involving significant others
    • Varenicline: effectiveness and safety
    • Managing post-cessation weight gain
    • Waterpipe tobacco smoking
    • Stop Smoking Services and Health Inequalities
    • Changes to the local stop smoking services quarterly data return for 2014 –15
  • Clinical tools
    • Cytisine
    • VBA+
    • Stop smoking medications quick reference sheet
    • Guidance on alternatives to Champix
    • Champix out of stock 2021
    • Standard treatment programme
    • NCSCT Standard Treatment Programme for Pregnant Wo
    • Remote consultation guidance
    • COVID-19 recommendation 21.01.21
    • COVID-19 recommendation 18.03.20
    • Standard monitoring form
    • Stop Smoking Service Client Record Form
    • Stop Smoking Service Client Satisfaction Questionnaire (full)
    • Client Satisfaction Questionnaire
    • The Russell Standard
  • NHS Community Pharmacy SCS
    • STP for SCS
    • STP for SCS PRINT
    • STP SCS Checklists
    • STP feedback form
  • Commissioning resources
    • Service e-cig advice
    • A Toolkit for Commissioners
    • 'Cut Down to Quit' with NRT
    • The effectiveness of NHS smoking cessation services: a systematic review
    • Competences required for delivering a STP
    • ASH SSK
  • Secondary care resources
    • How were these factsheets put together?
    • The clinical case for providing stop smoking support to hospitalised patients (2020)
    • Cardiovascular Patients Factsheet
    • Dental patient factsheet (2020)
    • Diabetic Patients Factsheet
    • Mental Health Patients (2020)
    • Oncology Patients Factsheet
    • Paediatrics Factsheet
    • Pregnant Women Factsheet
    • Respiratory Patients factsheet
    • Rheumatology patient factsheet (2020)
    • Stroke patient factsheet (2020)
    • Surgical Patients Factsheet
    • Wound Care Factsheet
    • Supporting renal patients
    • Supporting ophthalmology patients
    • Neurology patients
    • Gynaecology patients
    • Ear, nose and throat patients
    • Orthopedic Patients Factsheet
  • Research resources
    • Dependence on smoking
    • Health questionnaire
    • Mood and physical symptoms scale (MPSS)
    • Motivation to stop smoking
    • Social support
    • Past quit attempts
    • Physical activity questionnaire
    • Smoking motives
    • Consent form
  • NICE guidance
    • NICE Guidance NG209 Tobacco
    • Behaviour Change at Population, Community and Individual Levels (NICE, October 2007)
  • Department of Health Guidance
    • Tobacco Plan 2017-22
    • Tobacco control delivery plan 2017 to 2022
    • Local Stop Smoking Services: Service and delivery guidance 2014
    • The Operating Framework for the NHS in England 2012/13
    • Service Delivery and Monitoring Guidance: summary
    • Service Delivery and Monitoring Guidance 2011/12
    • Healthy Lives, Healthy People: A Tobacco Control Plan for England - Summary (March 2011)
    • Healthy Lives, Healthy People Tobacco Control Plan
    • Healthy Lives, Healthy People: strategy
  • Cochrane reviews: behaviour intervention
    • Behavioural interventions for smoking cessation: an overview and network meta-analysis
    • Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
    • Smoking reduction interventions for smoking cessation
    • Psychosocial interventions for supporting women to stop smoking during pregnancy
    • Individual behavioural counselling for smoking cessation
    • Group behaviour therapy programmes for smoking cessation
    • Internet-based interventions for smoking cessation
    • Mobile phone text messaging and app-based interventions for smoking cessation
    • Telephone counselling for smoking cessation
    • Print-based self-help interventions for smoking cessation
    • Enhancing partner support to improve smoking cessation
    • Psychosocial interventions for patients with CHD
    • Exercise interventions for smoking cessation
    • Motivational interviewing for smoking cessation
    • Smoking cessation for chronic obstructive pulmonary disease
    • Relapse prevention interventions for smoking cessation
  • Cochrane reviews: pharmacological interventions
    • Nicotine replacement therapy versus control for smoking cessation
    • Nicotine receptor partial agonists for smoking cessation
    • Antidepressants for smoking cessation
    • Pharmacological interventions for smoking cessation: an overview and network meta‐analysis
    • Pharmacological interventions for promoting smoking cessation during pregnancy
    • NRT Doses and duration
    • Combined pharmacotherapy and behavioural interventions for smoking cessation
    • Interventions to increase adherence to medications for tobacco dependence
  • Cochrane reviews: community interventions
    • Community interventions for reducing smoking among adults
    • Community pharmacy personnel interventions
    • Competitons for smoking cessation
    • Reducing children's exposure to tobacco
    • Nursing interventions for smoking cessation
    • Physician advice for smoking cessation
    • School-based programmes for preventing smoking
  • Cochrane reviews: interventions in other settings
    • Acupunture and related interventions
    • Biomedical risk assessment as an aid for smoking cessation
    • Hypnotherapy for smoking cessation
    • Interventions for preoperative smoking cessation
    • Interventions for smoking cessation in hospitalised patients (2020)



Champix out of stock 2021

Champix out of stock

28th October 2021
Today the Department of Health and Social Care issued an updated Supply Disruption Alert confirming that there is no resupply date of varenicline from Pfizer and no alternative supplier. See first attachment below.
--

14th October 2021
Pfizer, in agreement with the European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA), have announced that all Champix (varenicline) batches that were found to contain levels of N-nitroso-varenicline above the acceptable level of intake set at both EMA and MHRA level are being recalled at pharmacy and wholesale level. See Champix recall statement from Pfizer dated 14th October below.

There is no news on when supplies might recommence but it is unlikely to be in the short term.
--

25th June 2021
The second document below is a statement from Pfizer that identifies the presence of nitrosamines in some batches of Champix "above Pfizer’s acceptable level of daily intake (ADI)".

Some nitrosamines may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time. The statement goes on to say: "For those patients currently prescribed Champix we believe the benefits outweigh the very low potential risks, if any, posed by nitrosamine exposure from varenicline on top of other common sources over a lifetime."
--

24th June 2021
The third document below is a supply disruption alert issued by MHRA and the NHS.
--

23rd June 2021
We have updated the contact information for Pfizer from that contained in the announcement document of the 16th June.

Updated information: Further questions on switching medication and on supply of Champix can be addressed to Pfizer. The central number is 01304 616 161 and is manned between 9am to 5pm, calls to this number will be routed appropriately. Outside of these hours, enquiries can be submitted via an online form available at: www.pfizermedicalinformation.co.uk/en-gb/front
--

16th June 2021
Pfizer have announced that with immediate effect, there are supply issues with Champix (varenicline). Click on the icon below for the full announcement.
--

DHSC Supply Disruption Alert 28th October 2021

Champix recall statement from Pfizer 14th October 2021

Champix Supply Statement from Pfizer 25th June 2021

MHRA and NHS supply disruption alert 24th June 2021

Champix out of stock notice 16th June 2021



Back to previous page



T&A programme
 
VBA training module
 
SHS training module
 


NCSCT Training and Assessment Programme
Certified Practitioners
Mailing List
contact us (small)
twitter small
facebook small
youtube small
Links to other organisations
Announcements
 
    Need help?

T: 01305 755828

E: enquiries@ncsct.co.uk
National Centre for Smoking Cessation and Training

Community Interest Company

Registered in England and Wales No. 7394485